Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

被引：0
|
作者：
Park, Deborah Y. [1 ]
Poudel, Shyam K. [2 ]
Jia, Xuefei [3 ]
Wilks, Mailey Lynn [2 ]
Pinkava, Vicki [2 ]
O'Brien, Meghan [2 ]
Tripp, Barbara [2 ]
Song, Jung-Min [2 ]
McCrae, Keith R. [2 ]
Angelini, Dana E. [2 ]
Khorana, Alok A. [2 ]
机构：
[1] Cleveland Clin, Lerner Coll Med, Cleveland Hts, OH USA
[2] Cleveland Clin Fdn, Dept Hematol & Med Oncol, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-111897
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1237
引用
收藏
页数：4
相关论文
共 50 条
  • [41] LOW-MOLECULAR-WEIGHT HEPARINS FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM
    HULL, RD
    PINEO, GF
    ANNALS OF MEDICINE, 1993, 25 (05) : 457 - 462
  • [42] Low-molecular-weight heparins in the treatment of venous thromboembolism
    Walter Ageno
    Menno V Huisman
    Trials, 1 (2)
  • [43] TREATMENT OF VENOUS THROMBOEMBOLISM WITH LOW-MOLECULAR-WEIGHT HEPARINS
    HULL, RD
    PINEO, GF
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (05) : 1095 - 1103
  • [44] Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis
    Rungjirajittranon, Tarinee
    Owattanapanich, Weerapat
    Chinthammitr, Yingyong
    Ruchutrakool, Theera
    Suwanawiboon, Bundarika
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [45] Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis
    Tarinee Rungjirajittranon
    Weerapat Owattanapanich
    Yingyong Chinthammitr
    Theera Ruchutrakool
    Bundarika Suwanawiboon
    Thrombosis Journal, 20
  • [46] A ten-year comparison of treatment and outcomes of cancer-associated thrombosis to non-cancer venous thromboembolism: from traditional anticoagulants to direct oral anticoagulants
    Wee, Benjamin
    Lai, Jeffrey
    Khattak, Zille
    Kwok, Anna
    Donarelli, Cynthia
    Ho, Prahlad
    Lim, Hui Yin
    Lui, Brandon
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (04) : 658 - 667
  • [47] Direct oral anticoagulants and cancer: no swansong yet for the low-molecular-weight heparins
    Noble, Simon I. R.
    Lancet Haematology, 2016, 3 (08): : E357 - E358
  • [48] Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study
    Khan, Adeel M.
    Chiasakul, Thita
    Redd, Robert
    Patell, Rushad
    McCarthy, Ellen P.
    Neuberg, Donna
    Zwicker, Jeffrey I.
    PLOS MEDICINE, 2022, 19 (05)
  • [49] Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?
    Debourdeau, Philippe
    Cossou-Gbeto, Cresent
    Takam-Sohwe, Thierry
    Laroche, Jean-Pierre
    BULLETIN DU CANCER, 2020, 107 (02) : 224 - 233
  • [50] Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism What do we know so far?
    Voigtlaender, Minna
    Langer, Florian
    HAMOSTASEOLOGIE, 2017, 37 (04): : 241 - 255
12345